Russian Medical Society for Arterial Hypertension Expert Consensus: Hypertension and COVID-19
The novel coronavirus infection (COVID-19) caused by the b-coronavirus SARS-CoV-2, and leads to acute respiratory distress-syndrome, has affected more than nineteen million people worldwide, resulting in 0.7 million deaths as of August 2020. The fact that the virus uses angiotensin-converting enzyme...
Main Authors: | Irina E. Chazova, Natalia V. Blinova, Vera A. Nevzorova, Juliya V. Zhernakova, Mikhail P. Savenkov, Elena V. Oshchepkova, Olga D. Ostroumova, Oksana A. Kisliak, Sergey A. Boytsov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Morozov P.V.
2020-10-01
|
Series: | Системные гипертензии |
Subjects: | |
Online Access: | https://syst-hypertension.ru/2075-082X/article/viewFile/44221/pdf |
Similar Items
-
Renin inhibitors are a new direction in the treatment of arterial hypertension
by: Yuriy Aleksandrovich Vasyuk, et al.
Published: (2010-09-01) -
Effect of Ramipril on Renin-Angiotensin-Aldosterone System of Young and Middle-Aged Patients with Hypertension
by: Hui-Ling Yuan
Published: (2020-12-01) -
Genetic pathogenesis of essential arterial hypertension (the review)
by: Ruta A.V., et al.
Published: (2011-03-01) -
The Vasoactive Mas Receptor in Essential Hypertension
by: Amalie L. Povlsen, et al.
Published: (2020-01-01) -
Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
by: M L Maksimov
Published: (2010-06-01)